COL17A1 and inflammatory skin disease: reported that 7.2% of patients with non-inflammatory skin diseases, including leg ulcers, basal cell carcinoma, and squamous cell carcinoma, had anti-BP180 autoantibodies detected by BIOCHIP, although the details were not mentioned (22).